ArticleDiabetologia2026

Comparative hepatic effectiveness of empagliflozin vs dapagliflozin among individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.

Suyeon Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.